Bioreliance Corporation
UEI H3KAG9A26K77 · MD · subsidiary of Merck Kommanditgesellschaft Auf Aktien · SAM.gov record ↗
$103K
FY2025 obligations
5
Contract awards
Jan 21, 2021
First action
May 28, 2026
Latest action
Obligations by agency
- Department Of Health And Human Services$103K
Obligations by NAICS
Monthly obligations
Nov 24
Jan 25
May 25
Jun 25
May 26
Contracts ending within 18 months (recompete watch)
| PIID | Description | Agency | NAICS | Obligated | Start | End |
|---|---|---|---|---|---|---|
| 75D30124P19870 ↗ | FOLLOW-UP TESTING FOR TUMORIGENICITY AND ONCOGENICITY. | Centers For Disease Control And Prevention | 621511 | $0 | Sep 25, 2024 | Sep 23, 2026 |
| 75D30126P21070 ↗ | CRYOGENIC STORAGE OF CGMP GRADE CELL BANKS-EO 14398 | Centers For Disease Control And Prevention | 493120 | $43K | May 31, 2026 | May 30, 2027 |
Largest awards
| PIID | Description | Agency | NAICS | Obligated | Start | End |
|---|---|---|---|---|---|---|
| 75D30126P21070 ↗ | CRYOGENIC STORAGE OF CGMP GRADE CELL BANKS-EO 14398 | Centers For Disease Control And Prevention | 493120 | $43K | May 31, 2026 | May 30, 2027 |
| 75D30121P10233 ↗ | STORAGE RENEWAL FOR CDC VERO AND MDCK CELLS | Centers For Disease Control And Prevention | 541380 | $28K | Jan 21, 2021 | May 30, 2026 |
| 75N93025P00260 ↗ | BIORELIANCE CORP ENDOTOXIN AND STERILITY TESTING SERVICES | National Institutes Of Health | 541380 | $16K | Jan 20, 2025 | Jan 15, 2026 |
| 75D30121C10819 ↗ | BIORELIANCE EXPI293F | Centers For Disease Control And Prevention | 541714 | $16K | Jul 15, 2021 | Jul 14, 2026 |
| 75D30124P19870 ↗ | FOLLOW-UP TESTING FOR TUMORIGENICITY AND ONCOGENICITY. | Centers For Disease Control And Prevention | 621511 | $0 | Sep 25, 2024 | Sep 23, 2026 |